Rating History for Oyster Point Pharma (OYST) by Chardan

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2022 Daniil Gatauli Downgrade Neutral
(Buy)
13.00
(N/A)
8.35
(11.17)
33.77% Details